China Researchers Develop First Oral Vaccine Against Gastric Cancer
This article was originally published in PharmAsia News
Executive Summary
Chinese scientists report creation of the first oral vaccine to guard against gastric cancer. The Ministry of Science and Technology said the vaccine blocks stomach bacteria believed linked to development of duodenal and gastric ulcers as well as stomach cancer. The bacteria involved is Helicobactor pylori, defeated by the vaccine so far through Phase III trials, earning it the China State FDA's "first-grade new medicine" status. The vaccine, which already has intellectual property rights protection, demonstrated a 72.1 percent protection rate against Hp bacteria. (Click here for more